What's the reason. How would you rate it against other opiates/opioids?

Here tramadol used to be easy to get, it wasn't even seen as that addictive. Now just asking for tramadol will make it so you definitely don't get it, might as well ask for pharmaceutical heroin. The reason for this shift, as far as I can understand, is that for awhile India was sending out tons of tramadol powder and many got hooked.  This was apparently not seen when it was a prescription item and not popular in druggie circles. There's apparently some weird legislation where it's classed as a narcotic when in powder form but not when in pharma preps. I like it a lot, but my connect was out when I just asked. It's a pretty good painkiller but a mega effective immediate antidepressant 

If you are well versed then you would know all about various regenerative medicines and not think rehab meant just doing exercise in a vacuum. Dr don't discuss it either anything not covered by insurance doesn't get discussed it is wrong and malpractice. I have to specifically ask my Dr questions and you know what? They don't know the answers it's bad. Everyone wants to be some kind of specialist no one realizes you also need to be a generalist to be a good specialist.

Oak or Abe G, can you refute the graphs Gym Rat has posted? With evidence not silly memes (Oak).

WASHINGTON (AP) — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

The DEA’s proposal, which still must be reviewed by the White House Office of Management and Budget, would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than some of the nation’s most dangerous drugs. However, it would not legalize marijuana outright for recreational use.

The agency’s move, confirmed to the AP on Tuesday by five people familiar with the matter who spoke on the condition of anonymity to discuss the sensitive regulatory review, clears the last significant regulatory hurdle before the agency’s biggest policy change in more than 50 years can take effect.


Once OMB signs off, the DEA will take public comment on the plan to move marijuana from its current classification as a Schedule I drug, alongside heroin and LSD. It moves pot to Schedule III, alongside ketamine and some anabolic steroids following a recommendation from the federal Health and Human Services Department. After the public comment period and a review by an administrative judge, the agency would eventually publish the final rule.